Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 3
1999 2
2000 2
2001 2
2002 2
2003 11
2004 5
2005 7
2006 6
2007 13
2008 11
2009 9
2010 12
2011 20
2012 26
2013 14
2014 24
2015 15
2016 21
2017 19
2018 11
2019 6
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

212 results
Results by year
Filters applied: . Clear all
Page 1
Extrahepatic morbidity and mortality of chronic hepatitis C.
Negro F, et al. Gastroenterology 2015 - Review. PMID 26319013
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its sequelae, ranging from cutaneous and visceral vasculitis to glomerulonephritis and B-cell non-Hodgkin lymphoma. HCV-infected patients have increased rates of insulin resistance, diabetes, and atherosclerosis, which may lead to increased cardiovascular morbidity and mortality. ...
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may
[Mortality due to chronic viral hepatitis B and C infections in the Netherlands].
Hofman R, et al. Ned Tijdschr Geneeskd 2016. PMID 27734776 Dutch.
OBJECTIVE: To estimate mortality due to chronic hepatitis B-virus (HBV) and hepatitis C-virus (HCV) infections in the Netherlands from 2002 to 2015. ...HCC mortality due to viral hepatitis was higher in Dutch people of non-western origin. CONCLUSION: Mortality from chronic viral hepatitis is mostly the result of cirrhosis of the liver and HCC. ...
OBJECTIVE: To estimate mortality due to chronic hepatitis B-virus (HBV) and hepatitis C-virus (HCV) infec …
Trends in hepatitis C-related mortality in Switzerland.
Keiser O, et al. J Viral Hepat 2018. PMID 29159841
In order to accurately assess the burden of hepatitis C (HCV) and develop effective interventions, we must understand the magnitude and trends of mortality related to the disease. ...We compared HCV-related mortality to HIV-related and hepatitis B (HBV)-related mortality. To determine potential under-reporting in HCV-related mortality, we probabilistically linked the SFSO data to persons who died in the Swiss Hepatitis C Cohort Study (SCCS). ...
In order to accurately assess the burden of hepatitis C (HCV) and develop effective interventions, we must understand the magn …
Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
Mena A, et al. HIV Med 2017. PMID 28230318 Free article.
OBJECTIVES: The aim of this study was to compare liver-related mortality and liver-related hospitalizations for persons living with HIV (PLWH) with and without hepatitis C virus (HCV) exposure, and to estimate the fraction of liver disease attributable to chronic HCV coinfection. ...Sixty per cent of liver-related mortality in chronically HCV-coinfected PLWH could be attributable to chronic HCV infection. ...
OBJECTIVES: The aim of this study was to compare liver-related mortality and liver-related hospitalizations for persons living with H …
Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of Findings.
Moorman AC, et al. Infect Dis Clin North Am 2018 - Review. PMID 29778254 Free PMC article.
Chronic Hepatitis Cohort Study (CHeCS) publications using data from "real-world" patients with hepatitis C virus (HCV) have described demographic disparities in access to care; rates of advanced liver disease, morbidity, and mortality (2.5%-3.5% per year during 2006-10, although only 19% of all CHeCS decedents, and just 30% of those with deaths attributed to liver disease, had HCV listed on death certificate); substantial comorbidities, such as diabetes, advanced liver fibrosis (29% prevalence), renal disease, and depression, and partial reversal of all these with successful antiviral therapy; patient risk behaviors; and use of noninvasive markers to assess liver disease....
Chronic Hepatitis Cohort Study (CHeCS) publications using data from "real-world" patients with hepatitis C virus
Liver mortality attributable to chronic hepatitis C virus infection in Denmark and Scotland--using spontaneous resolvers as the benchmark comparator.
Innes H, et al. Hepatology 2016. PMID 26773546
Liver mortality among individuals with chronic hepatitis C (CHC) infection is common, but the relative contribution of CHC per se versus adverse health behaviors is uncertain. We explored data on spontaneous resolvers of hepatitis C virus (HCV) as a benchmark group to uncover the independent contribution of CHC on liver mortality. ...
Liver mortality among individuals with chronic hepatitis C (CHC) infection is common, but the relative contribut …
The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort-study.
Innes H, et al. Hepatology 2018. PMID 28777874
In resource-rich countries, chronic hepatitis C (CHC) infection is associated with a sizeable excess mortality risk. The extent to which this is due to (1) the biological sequelae of CHC infection versus (2) a high concomitant burden of health risk behaviors (HRBs) is unclear. ...The remedial response to hepatitis C must not neglect action on HRBs if it is to fully resolve the high mortality problem in this population. ...
In resource-rich countries, chronic hepatitis C (CHC) infection is associated with a sizeable excess mortality r …
Capacity to report on mortality attributable to chronic hepatitis B and C infections by Member States: An exercise to monitor progress towards viral hepatitis elimination.
Duarte G, et al. J Viral Hepat 2018. PMID 29479771
Viral hepatitis is globally leading causes of death, and 96% of these are due to hepatitis B and C (HBV/HCV) late outcomes. The first Global Health Sector Strategy (GHSS) aims to reduce by 65% the mortality associated with HBV/HCV, and an indicator (C10) is proposed to monitor progress. Data on viral hepatitis and liver-related mortality are required, and different methods of estimation can be used, depending on availability and quality of sources. ...
Viral hepatitis is globally leading causes of death, and 96% of these are due to hepatitis B and C (HBV/HCV) late outco …
Mortality Rates in Patients With Chronic Hepatitis C and Cirrhosis Compared With the General Population: A Danish Cohort Study.
Hallager S, et al. J Infect Dis 2017 - Clinical Trial. PMID 27803168
BACKGROUND: Knowledge about mortality rates (MRs) in patients with chronic hepatitis C (CHC) with cirrhosis is limited. This study aimed to estimate all-cause MRs among patients with CHC with or without cirrhosis in Denmark compared with the general population. METHODS: Patients registered in the Danish Database for Hepatitis B and C with CHC and a liver fibrosis assessment were eligible for inclusion. ...
BACKGROUND: Knowledge about mortality rates (MRs) in patients with chronic hepatitis C (CHC) with cirrhosis is l …
Monitoring response to hepatitis B and C in EU/EEA: testing policies, availability of data on care cascade and chronic viral hepatitis-related mortality - results from two surveys (2016).
Aspinall EJ, et al. HIV Med 2018. PMID 29488708 Free article.
The two surveys covered (A) availability of policy documents on testing; testing practices and monitoring; monitoring of diagnosis and treatment initiation, and; (B) availability of data on mortality attributable to chronic viral hepatitis. ...Corresponding figures for HCV were 48% (10/21) and 57% (12/21). 27% (6/22) of countries reported availability of data on mortality attributable to chronic viral hepatitis. ...
The two surveys covered (A) availability of policy documents on testing; testing practices and monitoring; monitoring of diagnosis and treat …
212 results
Jump to page
Feedback